EMA Committee Endorses AbbVie’s Elahere in Ovarian Cancer
ZacksIf approved, this will be the first regulatory approval for ABBV’s Elahere in the European Union.
If approved, this will be the first regulatory approval for ABBV’s Elahere in the European Union.